Tenascin-C in Osteoarthritis and Rheumatoid Arthritis.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 28 06 2020
accepted: 15 09 2020
entrez: 26 10 2020
pubmed: 27 10 2020
medline: 22 6 2021
Statut: epublish

Résumé

Tenascin-C (TNC) is a large multimodular glycoprotein of the extracellular matrix that consists of four distinct domains. Emerging evidence suggests that TNC may be involved in the pathogenesis of osteoarthritis (OA) and rheumatoid arthritis (RA). In this review, we summarize the current understanding of the role of TNC in cartilage and in synovial biology, across both OA and RA. TNC is expressed in association with the development of articular cartilage; the expression decreases during maturation of chondrocytes and disappears almost completely in adult articular cartilage. TNC expression is increased in diseased cartilage, synovium, and synovial fluid in OA and RA. In addition, elevated circulating TNC levels have been detected in the blood of RA patients. Thus, TNC could be used as a novel biochemical marker for OA and RA, although it has no specificity as a biochemical marker for these joint disorders. In a post-traumatic OA model of aged joints, TNC deficiency was shown to enhance cartilage degeneration. Treatment with TNC domains results in different, domain-specific effects, which are also dose-dependent. For instance, some TNC fragments including the fibrinogen-like globe domain might function as endogenous inducers of synovitis and cartilage matrix degradation through binding with toll-like receptor-4, while full-length TNC promotes cartilage repair and prevents the development of OA without exacerbating synovitis. The TNC peptide TNIIIA2 also prevents cartilage degeneration without causing synovial inflammation. The clinical significance of TNC effects on cartilage and synovium is unclear and understanding the clinical significance of TNC is not straightforward.

Identifiants

pubmed: 33101302
doi: 10.3389/fimmu.2020.577015
pmc: PMC7554343
doi:

Substances chimiques

Tenascin 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

577015

Informations de copyright

Copyright © 2020 Hasegawa, Yoshida and Sudo.

Références

Arthritis Rheumatol. 2017 Dec;69(12):2303-2313
pubmed: 29084415
Semin Cell Dev Biol. 2017 Feb;62:50-56
pubmed: 27771363
Osteoarthritis Cartilage. 2010 Jun;18(6):839-48
pubmed: 19747998
Biomed Res Int. 2019 Nov 22;2019:1475705
pubmed: 31886172
Adv Exp Med Biol. 2014;802:31-47
pubmed: 24443019
Arthritis Rheum. 2012 Jul;64(7):2055-8
pubmed: 22488656
Arthritis Res Ther. 2012 Nov 29;14(6):R260
pubmed: 23193984
Rheumatol Int. 2012 Sep;32(9):2809-17
pubmed: 21874326
J Cell Biol. 1987 Dec;105(6 Pt 1):2569-79
pubmed: 2447094
Arthritis Rheum. 1994 Jul;37(7):1013-22
pubmed: 7517675
Cartilage. 2020 Mar 23;:1947603520912300
pubmed: 32204600
Cell Mol Life Sci. 2019 Oct;76(20):3939-3952
pubmed: 31201464
J Mater Sci Mater Med. 2012 Oct;23(10):2575-82
pubmed: 22729594
Lancet. 2015 Jul 25;386(9991):376-87
pubmed: 25748615
Clin Exp Rheumatol. 2002 Sep-Oct;20(5):633-40
pubmed: 12412193
Dev Biol. 2008 Apr 1;316(1):62-73
pubmed: 18295755
J Rheumatol. 2008 Jan;35(1):147-52
pubmed: 18061975
FASEB J. 2017 May;31(5):1891-1902
pubmed: 28122919
Nat Rev Rheumatol. 2017 Oct;13(10):606-620
pubmed: 28835673
BMC Res Notes. 2020 Feb 17;13(1):78
pubmed: 32066496
Ann Rheum Dis. 2011 Oct;70(10):1713-8
pubmed: 21784723
J Orthop Res. 2007 May;25(5):563-8
pubmed: 17262825
Ann Phys Rehabil Med. 2016 Jun;59(3):134-138
pubmed: 26904959
Nat Commun. 2017 Nov 17;8(1):1595
pubmed: 29150600
Anat Rec (Hoboken). 2014 Sep;297(9):1747-57
pubmed: 25125186
Int J Mol Sci. 2018 Sep 07;19(9):
pubmed: 30205482
BMC Musculoskelet Disord. 2011 Jul 15;12:164
pubmed: 21762512
J Histochem Cytochem. 2018 Apr;66(4):289-304
pubmed: 29385356
Rheumatology (Oxford). 2014 Mar;53(3):415-24
pubmed: 24241034
Front Physiol. 2014 Jul 29;5:283
pubmed: 25120494
Bone. 2012 Aug;51(2):249-57
pubmed: 22387238
Osteoarthritis Cartilage. 2013 Feb;21(2):339-45
pubmed: 23142724
Cancer Res. 2001 Dec 1;61(23):8586-94
pubmed: 11731446
Ann Rheum Dis. 1957 Dec;16(4):494-502
pubmed: 13498604
Lancet. 2010 Sep 25;376(9746):1094-108
pubmed: 20870100
J Cell Biol. 1984 Jun;98(6):1937-46
pubmed: 6202699
J Orthop Res. 2015 Apr;33(4):563-71
pubmed: 25428773
Cell. 1988 May 6;53(3):383-90
pubmed: 2452695
Immunol Rev. 2008 Jun;223:7-19
pubmed: 18613827
Cartilage. 2018 Jan;9(1):80-88
pubmed: 29219023
J Orthop Surg Res. 2017 Mar 9;12(1):39
pubmed: 28279182
J Orthop Sci. 2010 Sep;15(5):666-73
pubmed: 20953929
Curr Opin Rheumatol. 2018 Mar;30(2):160-167
pubmed: 29227353
J Cell Biol. 1984 Jun;98(6):1926-36
pubmed: 6725406
Mol Biol Cell. 2004 Dec;15(12):5670-7
pubmed: 15483051
Matrix Biol. 2018 Oct;71-72:51-69
pubmed: 29803938
Cell Adh Migr. 2015;9(1-2):48-82
pubmed: 25482829
Int J Biochem Cell Biol. 2015 Aug;65:165-8
pubmed: 26055518
Cell Adh Migr. 2015;9(1-2):96-104
pubmed: 25793576
Ann Rheum Dis. 2007 Mar;66(3):334-40
pubmed: 17068066
Rheumatol Int. 2015 May;35(5):787-98
pubmed: 25261047
Technol Cancer Res Treat. 2019 Jan 1;18:1533033818821106
pubmed: 30803361
Allergy Asthma Clin Immunol. 2018 Nov 19;14:72
pubmed: 30473714
Int Immunopharmacol. 2018 May;58:15-23
pubmed: 29529488
Cell. 1989 Oct 20;59(2):325-34
pubmed: 2478295
J Rheumatol. 2004 Oct;31(10):2021-6
pubmed: 15468369
J Orthop Sci. 2020 Mar;25(2):324-330
pubmed: 30975540
J Immunol. 2009 Jun 15;182(12):8015-25
pubmed: 19494327
Ann Rheum Dis. 2016 Oct;75(10):1876-83
pubmed: 26659718
Ann Rheum Dis. 2019 Feb;78(2):186-191
pubmed: 30552174
Histopathology. 2006 Oct;49(4):358-64
pubmed: 16978198
Dev Biol. 2017 Jun 1;426(1):56-68
pubmed: 28438606
Arthritis Rheum. 2008 Mar;58(3):744-53
pubmed: 18311808
Am J Sports Med. 2010 Jun;38(6):1117-24
pubmed: 20181804
Nat Med. 2009 Jul;15(7):774-80
pubmed: 19561617
J Orthop Surg Res. 2016 Feb 02;11:19
pubmed: 26837951
Rheumatology (Oxford). 2012 Dec;51 Suppl 6:vi5-9
pubmed: 23221588

Auteurs

Masahiro Hasegawa (M)

Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Toshimichi Yoshida (T)

Department of Pathology & Matrix Biology, Mie University Graduate School of Medicine, Tsu, Japan.

Akihiro Sudo (A)

Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH